Seizo Masutani
- Oncology top 10%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Hepatology top 5%
- Cancer Research
- Co-authors
- Masayuki TatsutaHiroshi ImamuraTakashi SATOMIMasataka IkedaHideyuki IshidaHiroshi FurukawaJ ShimizuOsamu Ishikawa
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (10 papers)Pancreatic and Hepatic Oncology Research (6 papers)Liver physiology and pathology (4 papers)
- Cited by
- HepatologyOncologyInternal Medicine
- Partner nations
- Japan
In The Last Decade
Seizo Masutani
36 papers receiving 685 citations
Peers
Comparison fields: 5 of 59
- Oncology 367
- Surgery 214
- Pulmonary and Respiratory Medicine 210
- Hepatology 179
- Cancer Research 139
Countries citing papers authored by Seizo Masutani
This map shows the geographic impact of Seizo Masutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seizo Masutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seizo Masutani more than expected).
Fields of papers citing papers by Seizo Masutani
This network shows the impact of papers produced by Seizo Masutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seizo Masutani. The network helps show where Seizo Masutani may publish in the future.
Co-authorship network of co-authors of Seizo Masutani
This figure shows the co-authorship network connecting the top 25 collaborators of Seizo Masutani. A scholar is included among the top collaborators of Seizo Masutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seizo Masutani. Seizo Masutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function]. | 2 |
| 2 | [A case of pseudo aneurysm of common hepatic artery related to hepatic arterial infusion chemotherapy]. | 1 |
| 3 | 6 | |
| 4 | 44 | |
| 5 | 2 | |
| 6 | 248 | |
| 7 | 35 | |
| 8 | 43 | |
| 9 | 15 | |
| 10 | 41 | |
| 11 | 11 | |
| 12 | 24 | |
| 13 | [A case report of successful transcatheter arterial embolization therapy for osseous metastasis of hepatocellular carcinoma]. | 1 |
| 14 | 36 | |
| 15 | 24 | |
| 16 | Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus. | 45 |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 7 | |
| 20 | [Chemoembolization for liver metastasis from colorectal cancer]. | 3 |
About Seizo Masutani
Seizo Masutani is a scholar working on Hepatology, Oncology and Surgery, having authored 37 papers that have together received 712 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Hepatology (179 citations), Oncology (367 citations) and Internal Medicine (44 citations). Seizo Masutani has collaborated with scholars based in Japan. Frequent co-authors include Masayuki Tatsuta, Hiroshi Imamura, Takashi SATOMI, Masataka Ikeda, Hideyuki Ishida, Hiroshi Furukawa, J Shimizu, Osamu Ishikawa, Yo Sasaki and Shingi Imaoka. Their work appears in journals such as Analytical Biochemistry, Cancer Letters and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.